Empowering life sciences to advance a safer, healthier world.
microbiologics.com
Micromyx was founded in 2004 to support drug development by providing bacterial/fungal testing services. The Michigan SBDC Tech Team supported Micromyx to help it grow and meet key milestones before being acquired in 2019 by Microbiologics, a leading provider of microbiological testing controls, high-quality biomaterials and testing services. The current Kalamazoo location remains and continues to drive revenue and job creation in Michigan.
Key Accomplishments
-
Site expansions in both San Diego and Kalamazoo
-
Tissue culture expansion in Kalamazoo
-
Expansion of mycobacterial testing capabilities in Kalamazoo and using the BSL-3 in St. Cloud for screening new agents for activity against TB
-
Expansion of BSL-3 capacity and capabilities in San Diego
-
Development of SARS-COV-2 controls during the COVID pandemic to support diagnostic testing, biomaterials to support avian flu research, and assays to support vaccine development
-
Development of a genomics center in St. Cloud
-
Acquisition of SensID in Germany for development, manufacturing and marketing of reference material and QC in DNA diagnostics
-
Developed microbiology content for several INDs and NDAs of recently approved agents (e.g. rezafungin, arikayce, delafloxacin, sulopenem, and more)
Michigan SBDC Assistance
Tech Team Consulting
-
Business Strategy
-
Business Plan Review
-
Customer Discovery
-
Marketing/Sales Strategy
-
Financial Forecasting
-
Pricing Models
Additional Support From
-
$200,000 BRCC Funding in December 2004
-
$100,000 MEDC forgivable loan Dec. 2004. Loan forgiven based upon employment milestones.
Published May 2025